Marinus Pharmaceuticals, Inc.

MRNS · NASDAQ
Analyze with AI
9/30/2024
6/30/2024
3/31/2024
12/31/2023
Assets
Cash & Equivalents$42,184$64,676$104,253$120,572
Short-Term Investments$0$0$9,000$29,716
Receivables$3,840$3,435$3,513$3,799
Inventory$6,717$4,873$5,783$2,413
Other Curr. Assets$4,660$8,898$8,727$8,746
Total Curr. Assets$57,401$81,882$131,276$165,246
Property Plant & Equip (Net)$4,882$4,420$5,235$4,843
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$1,341$781$839$819
Total NC Assets$6,223$5,201$6,074$5,662
Other Assets$0$0$0$0
Total Assets$63,624$87,083$137,350$170,908
Liabilities
Payables$3,707$6,237$6,125$4,003
Short-Term Debt$14,279$12,328$16,707$14,536
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$16,518$17,302$19,926$22,085
Total Curr. Liab.$34,504$35,867$42,758$40,624
LT Debt$41,713$80,717$93,296$95,822
Deferred Rev, NC$36,039$17,844$17,730$17,545
Deferred Tax Liab, NC$0$0-$17,730$0
Other NC Liab.$18,108$0$0$152
Total NC Liab.$95,860$98,561$111,026$113,519
Other Liabilities$0$0$0$0
Cap. Leases$804$989$1,888$1,407
Total Liabilities$130,364$134,428$153,784$154,143
Equity
Pref Stock$0$0$0$0
Common Stock$55$55$55$55
Retained Earnings-$670,648-$646,423-$610,595-$571,926
AOCI$0$0$0-$20
Other Equity$603,853$599,023$594,106$588,656
Total Equity-$66,740-$47,345-$16,434$16,765
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$63,624$87,083$137,350$170,908
Net Debt$13,808$28,369$5,750-$10,214
Marinus Pharmaceuticals, Inc. (MRNS) Financial Statements & Key Stats | AlphaPilot